Supplements on GLP-1 Medications — Protein, Fiber, Muscle and Nutrient Intake

GLP-1-based medications such as semaglutide and tirzepatide can make meaningful weight loss possible for people who have struggled with obesity, insulin resistance and related metabolic disease.

The same reduction in appetite that helps people eat less also changes the nutritional conversation.

A smaller amount of food has to do more work. Protein still has to support muscle. Fiber and fluid still have to support gastrointestinal function. Vitamins and minerals still have to come from somewhere. Resistance training still has to give skeletal muscle a reason to remain.

This is where supplements can become useful. A protein shake may help someone reach a protein target when a full meal feels impossible. Creatine can support a resistance-training program. Fiber can help when dietary intake is low and constipation develops. A multivitamin may make sense when total food intake has become very limited or major food groups have disappeared from the diet.

The purpose is not to create a mandatory GLP-1 supplement stack. It is to identify what reduced food intake is no longer providing reliably and address that problem without losing sight of the medication dose, the diet and the quality of the weight being lost.

For the broader HormoneSynergy® approach to vitamins, minerals and supplement decisions, start with What Vitamins Should I Take? An Evidence-Based Guide to Supplements, Nutrient Gaps, Testing & Safety.

GLP-1 Treatment Changes the Amount of Food You Can Work With

Semaglutide, tirzepatide and other GLP-1-based medications reduce appetite, increase satiety and change the amount of food many people want or are able to eat.

The 2025 joint advisory from the American College of Lifestyle Medicine, American Society for Nutrition, Obesity Medicine Association and The Obesity Society notes that calorie intake can fall substantially during treatment. Reductions of roughly 16% to 39% have been observed in studies.

That reduction can be metabolically useful. It can also create a nutritional problem when the remaining calories come from foods that provide little protein, fiber or micronutrient density.

A person who once consumed 2,400 calories may have had plenty of opportunities during the day to obtain protein, vegetables, fruit, minerals and essential fatty acids. If intake falls to 1,200 or 1,400 calories, there is less room for foods that contribute little nutritionally.

The practical response is not to fight appetite suppression with oversized meals. It is to make the food that remains more useful.

Protein Comes First Because Weight Loss Includes Lean Tissue

Some decline in lean tissue occurs during most substantial weight loss, whether the weight is lost through calorie restriction, bariatric surgery or medication-assisted treatment.

GLP-1 therapy is no exception.

In the STEP 1 body-composition substudy, semaglutide produced large reductions in total body weight, fat mass and visceral fat. Absolute lean body mass also decreased, although lean tissue represented a larger proportion of total body weight after treatment because fat mass fell more substantially.

The SURMOUNT-1 DXA substudy provides similar context for tirzepatide. Over 72 weeks, body weight fell by 21.3%, fat mass by 33.9% and lean mass by 10.9%. Roughly three-quarters of the weight lost was fat mass and about one-quarter was lean mass.

Those numbers need careful interpretation. DEXA-derived lean mass is not the same thing as skeletal muscle. Lean tissue includes water, organs and other nonfat tissue. A decline in measured lean mass therefore does not mean that every pound represents functional muscle loss.

It still gives us a good reason to protect muscle deliberately.

How Much Protein Is Enough?

The standard adult Recommended Dietary Allowance for protein is 0.8 g/kg/day. That amount was developed to prevent deficiency in the general population, not specifically to maximize muscle preservation during active weight reduction.

Higher protein intakes are commonly used during weight loss and resistance training. The GLP-1 nutrition advisory discusses targets around 1.2–1.6 g/kg/day during active weight reduction.

The calculation becomes more complicated in obesity because using actual body weight can produce unrealistically high protein targets. Adjusted body weight, goal weight or measured lean mass may be more appropriate depending on the individual.

One practical alternative offered in the advisory is an absolute target of approximately 80–120 grams of protein per day for many adults.

That is a useful starting range rather than a prescription for everyone. Age, sex, lean mass, kidney function, activity level, total calorie intake and the amount of resistance exercise all affect the final target.

Eat the Protein Before Appetite Disappears

Early satiety creates a practical problem: someone may begin a meal planning to eat protein, vegetables and other foods, then feel full after a few bites of bread, crackers or another low-protein food.

The joint advisory suggests placing protein-rich foods early in the meal so they are more likely to be eaten before fullness becomes limiting.

Useful lower-volume foods include eggs, Greek yogurt, cottage cheese, fish, poultry, tofu, beans, lentils, nuts and nut butters.

The exact mix should fit the person's dietary preferences and tolerance. A plant-forward Mediterranean pattern can provide substantial protein without requiring every meal to revolve around meat.

Protein Powder Becomes Useful When Food Is No Longer Enough

Protein powder is not mandatory simply because someone is taking a GLP-1 medication.

It becomes useful when meeting an appropriate protein target through ordinary food is becoming difficult.

A well-formulated shake can provide a meaningful protein dose in a relatively small volume. That can be particularly helpful at breakfast, after strength training, during periods of nausea or on days when early satiety makes solid food difficult.

Protein supplements should still fit into the day's total intake rather than being added automatically on top of adequate food.

HormoneSynergy® may use Metagenics® UltraMeal Advanced Protein when a patient needs a convenient way to increase protein and overall nutrient density during weight loss.

The stronger question is not whether everyone on semaglutide needs a protein shake. It is whether the person is consistently meeting the amount of protein needed to preserve strength and lean tissue.

Protein Does Not Preserve Muscle by Itself

This is one of the most important parts of the GLP-1 nutrition conversation.

The 2025 joint advisory specifically cautions that increasing protein alone is unlikely to preserve muscle optimally without structured resistance exercise.

Skeletal muscle responds to use. Resistance training provides the mechanical stimulus that tells the body muscle remains necessary during an energy deficit.

Walking is valuable for cardiovascular health, glucose control, mobility and energy expenditure. Aerobic exercise belongs in a comprehensive weight-loss plan. Neither substitutes completely for loading muscle.

Strength training at least two or three times each week, appropriately scaled to the person's experience and physical ability, gives protein somewhere useful to go.

This is why HormoneSynergy® treats muscle preservation as a system rather than a supplement decision.

For the deeper clinical discussion, see GLP-1 Weight Loss & Muscle Preservation.

Creatine Can Support the Training Side of the Plan

Creatine monohydrate is one of the better-studied nutritional supplements for strength, training performance and lean tissue support.

Its role during GLP-1 weight loss needs to be described accurately.

We do not yet have strong randomized evidence showing that creatine specifically prevents lean-mass loss caused by semaglutide or tirzepatide. That claim would go beyond the current evidence.

We do have substantial evidence that creatine can improve strength and augment lean-tissue gains when combined with resistance training. A 2025 systematic review and meta-analysis in older adults found that adding creatine to resistance training improved lean tissue mass and lower-body strength compared with training alone.

That makes creatine a reasonable adjunct when the actual plan includes lifting weights and eating enough protein.

HormoneSynergy® may use RetzlerRx® Creatine Monohydrate Powder as part of this type of muscle-preservation strategy.

Creatine is supportive. It does not compensate for chronically inadequate protein, excessive calorie restriction or the absence of resistance training.

The Scale Cannot Tell You Whether the Plan Is Working Well

A person can lose twenty pounds and have very different outcomes depending on what those pounds represented.

Losing predominantly visceral and subcutaneous fat while preserving strength and most lean tissue is a favorable body-composition change.

Reaching the same scale weight while becoming weaker, poorly nourished and less physically capable is a different outcome.

This is why body composition deserves a place beside body weight during GLP-1 therapy.

DEXA can estimate fat mass, lean mass, visceral adipose tissue and bone density. Serial bioimpedance measurements can provide additional practical feedback between DEXA studies when performed under reasonably consistent conditions.

HormoneSynergy® uses Hologic® DEXA bone-density and body-composition testing when knowing the composition of weight loss is likely to change the plan.

Fiber Still Matters When Appetite Falls

Eating less often means eating less fiber unless the diet is deliberately built around it.

Vegetables, fruit, beans, lentils, whole grains, nuts and seeds provide fiber along with vitamins, minerals and phytochemicals. These foods remain valuable during GLP-1 treatment even when portions become smaller.

Fiber also becomes relevant because constipation is common during treatment.

The 2025 joint advisory recommends adequate fluids and fiber from food as first-line nutritional measures for constipation. An international expert consensus likewise recommends maintaining both soluble and insoluble fiber from a variety of food sources.

The increase should usually be gradual. Suddenly adding a large amount of fiber to someone who already has pronounced fullness, bloating, nausea or slowed gastrointestinal transit can make that person feel worse rather than better.

A Fiber Supplement Can Fill a Real Gap

Food remains the preferred foundation because fiber-rich foods bring much more than fiber.

A supplemental source can still be useful when vegetable, fruit, legume and whole-grain intake is low or when dietary fiber alone is not maintaining bowel regularity.

Soluble fiber can also contribute to satiety, glucose regulation and bowel function.

HormoneSynergy® carries RetzlerRx® UltraFiber Synergy Powder as one option for people who need additional soluble fiber.

Fiber supplements should be increased thoughtfully and taken with adequate fluid. Persistent or severe constipation deserves medical assessment rather than repeated increases in fiber without considering the medication dose, hydration, bowel function and other causes.

More Fiber Is Not Always Better During Nausea or Severe Fullness

Fiber normally supports gastrointestinal and metabolic health, but GLP-1 treatment changes gastric emptying and meal tolerance.

During periods of substantial nausea or early fullness, high-volume meals or very large amounts of fiber can be difficult to tolerate. The joint advisory notes that foods high in fiber, protein or fat may further slow gastric emptying in some people.

That does not mean fiber should be removed from the diet. It means gastrointestinal symptoms should guide the pace.

Someone tolerating treatment well can continue building a fiber-rich diet. Someone struggling to finish a few bites of food may need smaller portions, softer foods and more gradual progression while the medication regimen is reviewed.

Hydration Can Become Easier to Forget

People do not obtain fluid only from a glass of water. Food contributes meaningful water throughout the day.

When food intake falls, total fluid intake may fall with it. Nausea can make drinking less appealing, while vomiting or diarrhea can create additional losses.

Steady fluid intake throughout the day is generally easier to tolerate than trying to drink a very large amount at once when gastric fullness is already present.

Hydration becomes particularly important when constipation develops.

People with heart failure, kidney disease or another condition requiring fluid restriction should follow individualized medical guidance rather than generic hydration targets.

Electrolyte Powders Are Not Automatically Required

Electrolyte products have become part of the GLP-1 supplement market, but most people do not need a high-sodium electrolyte drink simply because they use semaglutide or tirzepatide.

They can be useful when vomiting, diarrhea, heavy sweating or very low food intake creates meaningful fluid and electrolyte losses.

The product should fit the situation. Some electrolyte powders provide substantial sodium. Others contain potassium that may be inappropriate for someone with kidney disease or medications that already raise potassium.

Water and ordinary food remain sufficient for many people.

Magnesium Has a Practical Role for Some Patients

Magnesium intake can fall when people eat fewer nuts, seeds, beans, whole grains and leafy vegetables.

It may also have a practical role when constipation develops.

The joint GLP-1 nutrition advisory lists magnesium supplementation, particularly magnesium citrate, among possible strategies when fluid and dietary approaches are insufficient for bowel regularity.

This is different from saying every GLP-1 patient needs magnesium.

The choice depends on diet, kidney function, bowel symptoms and the amount already present in other supplements. Magnesium can also interact with certain medications, including some antibiotics.

Our Magnesium: Which Form, What It Does, and Who Actually Needs It? Mini Stack reviews the differences between common forms.

Micronutrients Become More Important as Calories Fall

Reduced calorie intake does not automatically cause a vitamin deficiency.

It does make nutrient density more important.

The joint advisory identifies iron, calcium, magnesium, zinc and vitamins A, D, E, K, B1, B12 and C among nutrients that can become inadequate when food intake becomes very low or dietary variety narrows substantially.

This risk is not created solely by the medication. Many people beginning treatment already have diets low in vegetables, fruit, whole grains and other nutrient-dense foods. A 2026 analysis of U.S. adults eligible for GLP-1 anti-obesity treatment found modestly higher inadequacy for several micronutrients even before treatment.

GLP-1 therapy can therefore reveal or deepen an existing nutritional gap if total food intake falls but diet quality does not improve.

When a Multivitamin May Make Sense

A multivitamin does not need to be part of every GLP-1 prescription.

The 2026 Standards of Care in Overweight and Obesity suggest considering a multivitamin-mineral supplement when intake becomes particularly limited, including people consuming fewer than about 1,200 calories per day, those avoiding major nutrient-rich food groups, strict vegetarians, older adults, people with conditions that impair absorption and those experiencing excessive weight reduction.

That is a more useful way to think about a multivitamin than simply pairing one automatically with the medication.

A basic multi can provide nutritional coverage when diet is temporarily restricted. It should not create a reason to ignore the quality of the food that remains.

Our Do I Need a Multivitamin? What the Evidence Actually Shows Mini Stack explains the broader evidence.

Iron Should Be Tested Rather Than Added Casually

Fatigue and hair shedding can occur during significant weight loss. Neither symptom proves iron deficiency.

Iron can also worsen constipation, which is already a common GLP-1 concern.

Ferritin, hemoglobin and, when appropriate, transferrin saturation provide a much better basis for deciding whether iron is needed.

Women with ongoing menstrual blood loss, people with previous bariatric surgery and patients with gastrointestinal disease may deserve particular attention to iron status.

Our Iron Supplements: When You Need Them, When You Don’t, and Why Testing Comes First Mini Stack covers this in detail.

B12 Deserves Attention When Other Risk Factors Are Present

A GLP-1 medication is not automatically a reason to start vitamin B12.

B12 becomes more relevant when the person also uses metformin, takes long-term acid-suppressing medication, follows a vegan diet, has gastrointestinal disease or has undergone bariatric surgery.

These are common enough combinations in metabolic medicine that they deserve attention.

When serum B12 is borderline, methylmalonic acid can sometimes clarify whether cellular B12 availability is inadequate.

Vitamin D and Calcium Belong in the Bone Conversation

Significant weight reduction can affect bone as well as muscle.

Calcium and vitamin D remain important for normal skeletal physiology, but neither should be added at high doses simply because someone started a GLP-1 medication.

Calcium intake should include food. Vitamin D dosing should reflect dietary intake, medical history and clinical indications for testing or treatment.

Exercise may be particularly valuable here. In a randomized study using liraglutide after weight loss, combining GLP-1 therapy with structured exercise preserved bone mineral density better than medication alone.

Resistance training therefore supports more than muscle.

What About Probiotics and “GLP-1 Gut Support”?

The gastrointestinal tract is clearly affected by GLP-1-based therapy, which has made probiotics and microbiome products a growing part of the supplement market.

The human evidence is not strong enough to say that everyone taking semaglutide or tirzepatide should take a probiotic.

Selected gut-support products may be useful when they address a specific digestive problem or dietary pattern, but they should not be presented as necessary companions to the medication.

Nausea, reflux, constipation, diarrhea and excessive fullness deserve to be understood clinically. Sometimes the best intervention is not another gut supplement. The medication dose, meal size, food composition or titration schedule may need attention.

The Medication Dose Is Part of the Nutrition Plan

Appetite suppression is useful until it becomes so strong that someone cannot eat enough to support normal nutrition, hydration and physical function.

Persistent inability to meet basic protein or calorie needs should not automatically trigger more shakes, vitamins and powders while the medication remains unchanged.

The dose may need review.

The 2026 Standards of Care explicitly note that if nutritional intake remains inadequate because of the effects of an obesity medication, healthcare professionals should consider reducing the medication dose.

This is an important part of medically supervised GLP-1 care. The goal is not maximum appetite suppression. It is sustainable improvement in body composition and metabolic health.

A Practical GLP-1 Nutrition and Supplement Framework

When Symptoms Deserve More Than a Supplement

Most gastrointestinal side effects improve as the body adapts to treatment, particularly when medication is titrated thoughtfully.

Some symptoms should not be managed indefinitely with fiber, magnesium, protein drinks or electrolyte powder.

Repeated vomiting, inability to keep fluids down, marked weakness, significantly reduced urination, persistent inability to eat, severe or persistent abdominal pain, progressive abdominal swelling or inability to pass stool or gas deserve prompt medical evaluation.

Nutrition support works best when the medication itself is being tolerated appropriately.

How HormoneSynergy® Approaches GLP-1 Nutrition

We are interested in the quality of the weight loss, not only the amount.

That means asking whether visceral fat is falling, whether muscle is being preserved, whether the person remains strong enough to train, whether protein intake is adequate and whether gastrointestinal symptoms are interfering with nutrition.

Body composition can help answer some of those questions. Protein targets and resistance training can then be adjusted according to the person rather than prescribed from a generic handout.

Supplements are used where they solve a recognizable problem. Protein support can close a dietary gap. Creatine can support the training program. Fiber or magnesium may help selected people with bowel regularity. A multivitamin can provide temporary coverage when food intake is unusually restricted.

The supplement list should remain secondary to the clinical structure around the medication.

HormoneSynergy®'s GLP-1 Weight Loss for Longevity™ Program is built around this broader approach to metabolic health, body composition, nutrition and muscle preservation.

Our related article, Nutrition on GLP-1 Medication: Protecting Muscle, Digestion and Nutrient Intake, looks more broadly at food selection and gastrointestinal management during treatment.

The HormoneSynergy® Perspective

GLP-1 medications have given clinicians a powerful way to treat obesity and improve metabolic health. Good nutrition makes that treatment better.

The strongest supplement strategy is surprisingly simple. Make sure protein intake is adequate. Use resistance training to preserve strength and muscle. Add creatine when it supports that training plan. Keep fiber and hydration adequate enough to support bowel function. Pay attention to vitamins and minerals when food intake becomes unusually low.

Most patients do not need every product marketed for GLP-1 weight loss.

They need enough nutrition to remain strong while losing excess fat.

That is the outcome worth protecting: less visceral fat, better metabolic health, preserved muscle, useful strength and a nutritional pattern that can continue after the most rapid phase of weight loss is over.

The central What Vitamins Should I Take? guide explains how we evaluate nutrient gaps, testing and supplement safety. Additional GLP-1, body-composition and longevity articles are available in the HormoneSynergy® Longevity Medicine Resource Library.

Frequently Asked Questions

What supplements should I take while using a GLP-1 medication?

There is no mandatory GLP-1 supplement stack. Protein supplementation may be helpful when food intake cannot meet protein needs. Creatine can support resistance training and strength. Fiber may help when dietary intake is low or constipation develops. A multivitamin can be considered when total food intake becomes very low or restrictive. Individual nutrients should generally address an identified dietary or clinical need.

How much protein should I eat on semaglutide or tirzepatide?

Protein needs are individualized. Intakes around 1.2–1.6 g/kg/day are commonly proposed during active weight reduction, although using actual body weight can overestimate requirements in people with obesity. An absolute target around 80–120 grams per day can be practical for many adults. Kidney function, lean mass, age, activity and medical history should be considered.

Should I drink protein shakes while taking a GLP-1?

Protein shakes are useful when early fullness or reduced appetite makes it difficult to meet protein needs through food. They are not necessary when dietary protein intake is already adequate.

Does creatine prevent muscle loss on GLP-1 medications?

Direct evidence that creatine specifically prevents GLP-1-associated lean-mass loss remains limited. Creatine does have strong evidence for supporting strength and lean-tissue gains when combined with resistance training, which makes it a reasonable adjunct within a muscle-preservation program.

How much muscle is lost on GLP-1 medications?

Body-composition changes vary considerably. In the SURMOUNT-1 DXA substudy with tirzepatide, approximately 75% of weight lost was fat mass and 25% was lean mass. In semaglutide studies, substantial fat and visceral-fat reductions occurred alongside some loss of absolute lean mass. DEXA-derived lean mass is not identical to skeletal muscle, so strength and physical function should also be considered.

Should I take fiber on semaglutide or tirzepatide?

Fiber from vegetables, fruit, beans, lentils, whole grains, nuts and seeds should remain part of the diet when tolerated. A fiber supplement can help when dietary intake is inadequate or constipation is present. Fiber should generally be increased gradually because large amounts can worsen bloating or fullness in some people.

Do GLP-1 medications cause vitamin deficiencies?

GLP-1 medications do not automatically cause vitamin deficiencies. Reduced calorie intake, restrictive eating, vomiting and limited dietary variety can increase the risk of inadequate intake. Iron, calcium, magnesium, zinc and several vitamins can become concerns when food intake is very low over time.

Should everyone taking a GLP-1 take a multivitamin?

No. A multivitamin becomes more reasonable when calorie intake is very low, major nutrient-rich food groups are excluded, malabsorption is present, weight loss is excessive or other nutritional risk factors exist. Targeted supplementation is preferable when a specific deficiency has been identified.

Do I need electrolytes on a GLP-1 medication?

Not necessarily. Ordinary food and fluids provide adequate electrolytes for many people. Electrolyte products may be useful during vomiting, diarrhea, heavy sweating or unusually low food intake. Sodium and potassium content should be considered in people with hypertension, kidney disease or medications that affect electrolyte balance.

What helps constipation on GLP-1 medications?

Regular fluid intake, gradual increases in dietary fiber and physical activity are useful starting points. Fiber supplements or magnesium may help selected patients. Persistent or severe constipation should be reviewed medically because simply adding more fiber is not always appropriate.

How should muscle be monitored during GLP-1 weight loss?

Scale weight alone cannot show whether weight is being lost from fat or lean tissue. DEXA or other validated body-composition measurements can help track fat mass and lean mass. Strength and physical function are also important because measured lean mass is not the same thing as functional skeletal muscle.

References

• Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity. 2025;33(8):1475-1503.
• Standards of Care in Overweight and Obesity. Pharmacologic Treatment of Obesity in Adults. 2026.
• Look M, Dunn JP, Kushner RF, et al. Body Composition Changes During Weight Reduction With Tirzepatide in the SURMOUNT-1 Study of Adults With Obesity or Overweight. Diabetes, Obesity and Metabolism. 2025.
• Wilding JPH, Batterham RL, Calanna S, et al. Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study. Journal of the Endocrine Society. 2021.
• Alissou M, et al. Impact of Semaglutide on Fat Mass, Lean Mass and Muscle Function in Patients With Obesity: The SEMALEAN Study. Diabetes, Obesity and Metabolism. 2026.
• Nutritional and Lifestyle Supportive Care Recommendations for Management of Obesity With GLP-1-Based Therapies: Expert Consensus Statement. 2026.
• Liu S, Huang N, Wu W, et al. The Impact of Creatine Supplementation Associated With Resistance Training on Muscular Strength and Lean Tissue Mass in the Aged: A Systematic Review and Meta-analysis. European Review of Aging and Physical Activity. 2025.
• Dietary Supplement Considerations During Glucagon-Like Peptide-1 Receptor Agonist Treatment: A Narrative Review. 2025.
• Babazadeh D, Zhong H, Steinberg FM. Diet Quality and Micronutrient Intake Among United States Adults Eligible for GLP-1 Receptor Agonist Antiobesity Medications: A Nationally Representative Analysis. Journal of Nutrition. 2026.

HormoneSynergy® provides this material for educational purposes. It is not intended to diagnose, treat, cure or prevent disease and does not replace individualized medical care. GLP-1-based medications and nutritional supplements can affect gastrointestinal function, hydration, medication tolerance and nutrient requirements. Significant or persistent gastrointestinal symptoms, inability to maintain food or fluid intake, severe abdominal pain or marked weakness warrant medical evaluation. Do not change the dose of a prescription medication without discussing it with the prescribing clinician.